As a patent lawyer with 25 years of experience, Dr. Martin Weber represents clients in the life sciences, biotechnology, pharmaceuticals, and chemistry sectors, focusing on patent prosecution, opposition and appeal proceedings, patent invalidation, and patent infringement. In addition, he advises on patent portfolio strategies in relation to regulatory and patent exclusivity involving patent term extensions (supplementary protection certificates) for medicinal and plant protection products within the European Communities.
Drawing on his training in chemistry and biochemistry, Martin has counseled clients in technologies involving inorganic, organic, and polymer chemistry; pharmaceuticals; biotechnology (such as functional genomics, proteomics, tissue engineering, and genetic engineering); biologics (antibodies, growth factors, and peptide drugs); therapies (such as antiviral and anti-angiogenic therapies, nanomedicine, gene therapy, and personalized medicine); and diagnostics.
Martin leads Jones Day's German and European patent prosecution team and is a former scholar of the German National Academic Foundation.
A Therapy for European Patent Term Extensions: The Neurim Case and Supplementary Protection Certificates for "New Therapeutic Applications" reprinted by Law360
- 2008Das neue Gendiagnostikgesetz, GoingPublic "Biotechnologie 2008"
- April 2003The Utility Model Revisited, Managing Intellectual Property
- September 2001Provisional Protection for Methods of Treatment, Managing Intellectual Property
- November 2000Chemical Compounds and equivalents, Managing Intellectual Property
- October 2000Supplementary Protection Certificates (2), Managing Intellectual Property
- June 1999Supplementary Protection Certificates, Managing Intellectual Property
- June 16-17, 2009Biotech Patenting - Drafting Successful Patent Applications for Biotechnology Related Inventions, 16th Forum (European Edition) Biotech Patenting Conference
- March 4-5, 2009Inventions and Patents, Science4Life Workshop, in connection with the Science4Life Venture Cup 2009
- September 23-24, 2008Intellectual Property Aspects in Formulating Co-Crystals, Pharmaceutical Co-Crystals 2008 Conference (Pharma IQ/IQPC)
- March 12-13, 2008Inventions and Patents, Science4Life Workshop, in connection with the Science4Life Venture Cup 2008
- September 11, 2007Patent law and strategic aspects in connection with developing pharmaceutical products and diagnostics, Seminar at the Chambers of Industry and Commerce
- July 11, 2006LifeSciences and Biotech Patents - Impact of the EU Biotechnology Guideline on the Protection of Innovations, Seminar at the Technology Center
- September 2, 2005LifeSciences and Biotech Patents - Impact of the EU Biotechnology Guideline on the Protection of Innovations, Seminar of the Innovation and Patent Center (IPC)
- February 8-10, 2004Canada, Europe, and the United States - Why you may need to understand different IP regimes to obtain an appropriate deal structure, 2nd Annual BioPartnering North America (BPN) conference
- University of Hamburg, Germany (Dr. rer. nat., 1989-1992); Philipps-University Marburg, Germany; University of Bristol, United Kingdom; University of Hamburg, Germany (Diploma in Chemistry 1989)
- European Patent Office (EPO), German Patent and Trademark Office (GPTO), German Federal Patent Court (BPatG), German Federal Supreme Court (BGH) in nullity appeal proceedings, German Federal Office for Plant Varieties (BSA), International Bureau of WIPO (IB), and Office for Harmonization in the Internal Market (OHIM, European Community Trademarks and Designs)
JUVE 2011/12, 2012/13, 2013/14, 2014/15, 2015/16, 2017/18, 2018/19: frequently recommended ("strong in trial")
Chambers Global 2012-2013: "highly recommended"
Chambers Europe 2012-2014: recommended as a "leading lawyer"
Best Lawyers/Handelsblatt 2014-2020: ranked as one of Germany's leading lawyers for biotechnology law and life sciences practice
Legal 500 Germany since 2015: distinguished; "Jones Day's team ‘gives companies the feeling of being the only client’ and ‘is always available’"
- English, German